BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24893049)

  • 1. Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.
    Thoeny HC; Froehlich JM; Triantafyllou M; Huesler J; Bains LJ; Vermathen P; Fleischmann A; Studer UE
    Radiology; 2014 Oct; 273(1):125-35. PubMed ID: 24893049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
    Birkhäuser FD; Studer UE; Froehlich JM; Triantafyllou M; Bains LJ; Petralia G; Vermathen P; Fleischmann A; Thoeny HC
    Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.
    Thoeny HC; Triantafyllou M; Birkhaeuser FD; Froehlich JM; Tshering DW; Binser T; Fleischmann A; Vermathen P; Studer UE
    Eur Urol; 2009 Apr; 55(4):761-9. PubMed ID: 19144456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer.
    Triantafyllou M; Studer UE; Birkhäuser FD; Fleischmann A; Bains LJ; Petralia G; Christe A; Froehlich JM; Thoeny HC
    Eur J Cancer; 2013 Feb; 49(3):616-24. PubMed ID: 23084842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.
    Jager GJ; Barentsz JO; Oosterhof GO; Witjes JA; Ruijs SJ
    AJR Am J Roentgenol; 1996 Dec; 167(6):1503-7. PubMed ID: 8956585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
    Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
    Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
    Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.
    Vandecaveye V; De Keyzer F; Vander Poorten V; Dirix P; Verbeken E; Nuyts S; Hermans R
    Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient.
    Nakayama J; Miyasaka K; Omatsu T; Onodera Y; Terae S; Matsuno Y; Cho Y; Hida Y; Kaga K; Shirato H
    J Comput Assist Tomogr; 2010 Jan; 34(1):1-8. PubMed ID: 20118713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
    Giannarini G; Petralia G; Thoeny HC
    Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
    Heesakkers RA; Jager GJ; Hövels AM; de Hoop B; van den Bosch HC; Raat F; Witjes JA; Mulders PF; van der Kaa CH; Barentsz JO
    Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI.
    Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH
    AJR Am J Roentgenol; 2015 Sep; 205(3):W328-34. PubMed ID: 26295669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging.
    Ohno Y; Hatabu H; Takenaka D; Higashino T; Watanabe H; Ohbayashi C; Yoshimura M; Satouchi M; Nishimura Y; Sugimura K
    Radiology; 2004 Jun; 231(3):872-9. PubMed ID: 15163823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
    Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
    Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
    Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S
    Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging.
    Hasegawa I; Boiselle PM; Kuwabara K; Sawafuji M; Sugiura H
    J Thorac Imaging; 2008 Aug; 23(3):157-61. PubMed ID: 18728541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
    Harisinghani MG; Barentsz J; Hahn PF; Deserno WM; Tabatabaei S; van de Kaa CH; de la Rosette J; Weissleder R
    N Engl J Med; 2003 Jun; 348(25):2491-9. PubMed ID: 12815134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
    Williams AD; Cousins C; Soutter WP; Mubashar M; Peters AM; Dina R; Fuchsel F; McIndoe GA; deSouza NM
    AJR Am J Roentgenol; 2001 Aug; 177(2):343-8. PubMed ID: 11461859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.